Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published 2024 | Published
Book Section - Chapter Open

Molecular Medical Devices for Nanoneurosurgery

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon Massachusetts Institute of Technology
  • 3. Arch Therapeutics Inc., Columbia, SC, USA
  • 4. Society for Brain Mapping and Therapeutics, Pacific Palisades, CA, USA
  • 5. National Centre for Nano-Bio-Electronics (NCNBE), Pacific Palisades, CA, USA
  • 6. Brain Technology and Innovation Park (BTIP), Pacific Palisades, CA, USA
  • 7. World Brain Mapping Foundation (WBMF), Pacific Palisades, CA, USA

Abstract

Nanoneurosurgery represents a groundbreaking paradigm in the central nervous system (CNS) therapeutic arena, providing unprecedented precision and potential for direct intervention. This review delves into the transformative potential of molecular nanoneurosurgery, with a particular focus on its application in treating conditions such as renovascular hypertension (RVHT) and intracerebral hemorrhage (ICH) in a rat model. Utilizing the self-assembling peptide (RADA)4, we demonstrate the therapeutic efficacy of this nanomaterial in mitigating hematoma expansion, reducing cell apoptosis and inhibiting inflammatory responses post-ICH. The surgical methodology employed encompasses a comprehensive sequence from the induction of RVHT, selection criteria based on systolic blood pressure, ICH induction, blood clot aspiration, and precise administration of (RADA)4, to the subsequent evaluations of hematoma volume, cell death, and inflammatory markers.

The results highlight a significant reduction in hematoma volume, TUNEL-positive cells, and iNOS-immunoreactive cells in the (RADA)4-treated group, showcasing the material’s protective and therapeutic potential. While this study sheds light on the promising applications of nanoneurosurgery, it also underscores the need for further research and development in this domain to enhance the precision, efficacy, and safety of such nanomaterials in clinical settings.

Moreover, nanoneurosurgery emerges as a pioneering approach in the realm of nerve repair, presenting innovative solutions with enhanced precision and potential for functional restoration. This review meticulously examines the advancements and applications of nanoneurosurgery, with a distinct emphasis on optic nerve repair, a challenging yet crucial domain within neurosurgery. We explore the utilization of self-assembling peptides such as (RADA)4, elucidating its role in promoting nerve regeneration and functional recovery in models of optic nerve injury.

Through a comprehensive analysis of surgical methodologies, this study highlights the intricate procedures involved in the administration of nanomaterials, emphasizing their therapeutic efficacy in mitigating damage, reducing inflammation, and enhancing neuronal regeneration. The outcomes underscore a significant improvement in nerve function and structural integrity, marking a promising step toward the development of effective treatments for optic nerve injuries. Additionally, the review discusses the broader implications of nanoneurosurgery in the central nervous system (CNS), showcasing its potential to address a spectrum of neurological disorders. The results emphasize the need for ongoing research, standardized protocols, and safety evaluations to fully harness the potential of nanoneurosurgery, ensuring its successful translation from experimental models to clinical practice.

Copyright and License (English)

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

Files

978-3-030-80662-0_20.pdf
Files (4.8 MB)
Name Size Download all
md5:bc3f810739fcbdbe60da4a3de31da4bd
4.8 MB Preview Download

Additional details

Created:
December 4, 2024
Modified:
December 4, 2024